Evidence map›Paper›PMID 34007047›Full record

ArticleLeukemia2021

Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.

Nikolay Mayanskiy, Polina Luchkina, Natalia Fedorova, Yuri Lebedin, Natalia Ponomareva

Abstract readLetterComment
In one paragraph

Article in Leukemia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. COVID-19 in Children with Cancer.Current oncology reports · 2022
    Review
  4. Article
  5. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Nikolay MayanskiyRussian Children Clinical Hospital, Pirogov Russian National Research Medical University, Moscow, Russia. mayanskiy.nikolay@gmail.com.ORCID http://orcid.org/0000-0001-8077-5313
Polina LuchkinaRussian Children Clinical Hospital, Pirogov Russian National Research Medical University, Moscow, Russia.
Natalia FedorovaRussian Children Clinical Hospital, Pirogov Russian National Research Medical University, Moscow, Russia.
Yuri LebedinXEMA Company, Moscow, Russia.ORCID http://orcid.org/0000-0003-4250-4322
Natalia PonomarevaRussian Children Clinical Hospital, Pirogov Russian National Research Medical University, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Leukemia, Lymphocytic, Chronic, B-CellAntibody FormationChildDisease OutbreaksHospitalsHumansSARS-CoV-2Seroconversion

Identifiers

PMID34007047
PMCPMC8129958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.